Events

Are healthcare investors spending too much too fast? Find out at MedCity INVEST March 28-30.

Register for MedCity INVEST at the Ritz Carlton in Chicago and be part of the conversation on healthcare investment trends. Attendees will also be able to take part in networking opportunities and hear health tech, medtech and pharma tech startups pitch to investors.

The MedCity INVEST conference is coming up March 28-30, attracting traditional and strategic investors and healthcare executives across providers, payers, big tech, medtech and startups with compelling content and networking opportunities. The event is held in collaboration with Mid-America Healthcare Investors Network (MHIN).

One of the compelling topics we’ll cover at the conference at the Ritz Carlton in Chicago is healthcare investment trends.

To view the full agenda, click here.

Are investors spending too much too fast?
Pre-money valuations have increased manifold. Unicorns aren’t a rare commodity anymore. Mega rounds are commonplace. Digital health is setting investment records by the quarter. Are investors spending too much too fast and how close are we to a correction? Learn from finance experts and venture capitalists about the investment trends in healthcare.

Sponsored by Toronto Stock Exchange & TSX Venture Exchange

The speakers for the panel include:

To register at the early bird rate of $995 by Feb 11, click here.

We’ll also spotlight startups in the INVEST Pitch Perfect startup pitch contest. Companies will compete in four categories:

  • Care Coordination and Value Based Care
  • Diagnostics 2.0
  • PharmaTech
  • Remote Patient Monitoring and Smart Devices

Among the judges evaluating startups for the contest are:

  • Nickolas Mark, Managing Director and Partner, Intermountain Ventures
  • Jane Rho, Investor, Venture Fund, Davita Venture Group
  • Ian Chiang, Partner, Flare Capital Partners
  • Jessica Federer, Partner, Boston Millennia Partners
  • Jeff Weness, Head of Digital Opportunities and Business Intelligence, Otsuka Pharmaceutical Companies (U.S.)
  • Blake Wu, Partner, NEA
  • Tom Olenzak, Managing Director, Strategic Investing, Independence Blue Cross